The present invention relates to a novel dibenzoxazepine derivative, its synthesis, and its use as an v integrin receptor antagonist. More particularly, the compound of the present invention is an antagonist of the integrin receptors v3 and v5 and therefor useful for inhibiting bone resorption, treating and/or preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, artheroscietosis, inflammatory arthritis, cancer and metastatic tumor growth.

 
Web www.patentalert.com

< Bioartificial filtration device for filtering blood to mimic kidney function

< Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides

> Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights

> Hydrophilic member precursor and pattern forming material that utilizes it, support for planographic printing plate, and planographic printing plate precursor
~ 00207